CAS: 2086772-26-9
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
JNJ-64619178 REF: TM-T15624CAS: 2086772-26-9 | 98.44% - 99.63% | 88.00 €~1,638.00 € | Wed 22 Jan 25 | |
JNJ-64619178 REF: 3D-LID77226CAS: 2086772-26-9 | Min. 95% | To inquire | Wed 12 Mar 25 |
JNJ-64619178
CAS:2086772-26-9
JNJ-64619178: selective, oral, pseudo-irreversible PRMT5 inhibitor (IC50: 0.14 nM), effective in lung cancer.
Formula:
C22H23BrN6O2
Purity:
98.44% - 99.63%
Color and Shape:
Solid
Molecular weight:
483.36
Ref: TM-T15624
1mg | 88.00 € | ||
5mg | 168.00 € | ||
10mg | 271.00 € | ||
25mg | 560.00 € | ||
50mg | 932.00 € | ||
100mg | 1,638.00 € | ||
1mL*10mM (DMSO) | 182.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025
JNJ-64619178
CAS:2086772-26-9
JNJ-64619178 is a novel small molecule that targets the methyltransferase domain of the protein PRMT5. …
Formula:
C22H23BrN6O2
Purity:
Min. 95%
Molecular weight:
483.36 g/mol
Ref: 3D-LID77226
1mg | 260.00 € | ||
2mg | 381.00 € | ||
5mg | 542.00 € | ||
10mg | 775.00 € | ||
25mg | 1,154.00 € |
Estimated delivery in United States, on Wednesday 12 Mar 2025